TCRT icon

Alaunos Therapeutics

128 hedge funds and large institutions have $237M invested in Alaunos Therapeutics in 2017 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 31 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

0% less ownership

Funds ownership: 0.27%0.27% (-0%)

33% less capital invested

Capital invested by funds: $356M → $237M (-$119M)

55% less call options, than puts

Call options by funds: $3.06M | Put options by funds: $6.77M

Holders
128
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.06M
Puts
$6.77M
Net Calls
Net Calls Change

Top Buyers

1 +$5.74M
2 +$1.26M
3 +$1.16M
4
Citigroup
Citigroup
New York
+$1.12M
5
MVP
Miller Value Partners
Florida
+$935K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$40.2M
2
$35.2M
3
$35.2M
4
$24.1M
5
$21M
6
$14.1M
7
$6.83M
8
$6.5M
9
$6.22M
10
$4.8M
11
$3.39M
12
$2.67M
13
$2.67M
14
$2.54M
15
$1.27M
16
$1.26M
17
$1.26M
18
$1.22M
19
$1.21M
20
$1.06M
21
$1.05M
22
$1.02M
23
$906K
24
$896K
25
$883K